Original title: big Motors: maintain Shenwei Pharmaceutical (02877) "hold" rating target price increased by 13% to HK $7.80 Source: Zhitong Finance Network

JTO Financial APP learned that Morgan Stanley released a research report saying that the new dividend plan based on Shenwei Pharmaceutical (02877) actually guaranteed 15 per cent annual profit growth over the next few years, and raised its profit forecast for 2021-25 by 10 per cent to 13 per cent, which is expected to be mainly driven by an increase in sales, raising the dividend ratio forecast. Morgan Stanley updated the company's risk return, raising its target price by 13% from HK $6.9 to HK $7.8, maintaining its "hold" rating.